nodes	percent_of_prediction	percent_of_DWPC	metapath
L-DOPA—Distress—Ursodeoxycholic acid—primary biliary cirrhosis	0.0259	0.0351	CcSEcCtD
L-DOPA—Distress—Chenodeoxycholic acid—primary biliary cirrhosis	0.0259	0.0351	CcSEcCtD
L-DOPA—Emotional distress—Chenodeoxycholic acid—primary biliary cirrhosis	0.0169	0.0229	CcSEcCtD
L-DOPA—Emotional distress—Ursodeoxycholic acid—primary biliary cirrhosis	0.0169	0.0229	CcSEcCtD
L-DOPA—Duodenal ulcer—Ursodeoxycholic acid—primary biliary cirrhosis	0.0149	0.0201	CcSEcCtD
L-DOPA—Duodenal ulcer—Chenodeoxycholic acid—primary biliary cirrhosis	0.0149	0.0201	CcSEcCtD
L-DOPA—Heartburn—Ursodeoxycholic acid—primary biliary cirrhosis	0.0105	0.0141	CcSEcCtD
L-DOPA—Heartburn—Chenodeoxycholic acid—primary biliary cirrhosis	0.0105	0.0141	CcSEcCtD
L-DOPA—Blood disorder—Colchicine—primary biliary cirrhosis	0.0096	0.013	CcSEcCtD
L-DOPA—Cardiovascular disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.0082	0.0111	CcSEcCtD
L-DOPA—Cardiovascular disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.0082	0.0111	CcSEcCtD
L-DOPA—Musculoskeletal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00729	0.00985	CcSEcCtD
L-DOPA—Musculoskeletal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00729	0.00985	CcSEcCtD
L-DOPA—Urinary incontinence—Ursodeoxycholic acid—primary biliary cirrhosis	0.00695	0.0094	CcSEcCtD
L-DOPA—Urinary incontinence—Chenodeoxycholic acid—primary biliary cirrhosis	0.00695	0.0094	CcSEcCtD
L-DOPA—Vascular purpura—Colchicine—primary biliary cirrhosis	0.0065	0.00879	CcSEcCtD
L-DOPA—Sleep disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00604	0.00816	CcSEcCtD
L-DOPA—Sleep disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00604	0.00816	CcSEcCtD
L-DOPA—Purpura—Colchicine—primary biliary cirrhosis	0.00604	0.00816	CcSEcCtD
L-DOPA—Gastrointestinal haemorrhage—Colchicine—primary biliary cirrhosis	0.00582	0.00786	CcSEcCtD
L-DOPA—Haemolytic anaemia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00579	0.00783	CcSEcCtD
L-DOPA—Haemolytic anaemia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00579	0.00783	CcSEcCtD
L-DOPA—Blood creatinine increased—Colchicine—primary biliary cirrhosis	0.00545	0.00737	CcSEcCtD
L-DOPA—Cramp muscle—Colchicine—primary biliary cirrhosis	0.00524	0.00708	CcSEcCtD
L-DOPA—Diplopia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00523	0.00707	CcSEcCtD
L-DOPA—Gastrointestinal haemorrhage—Ursodeoxycholic acid—primary biliary cirrhosis	0.00523	0.00707	CcSEcCtD
L-DOPA—Diplopia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00523	0.00707	CcSEcCtD
L-DOPA—Gastrointestinal haemorrhage—Chenodeoxycholic acid—primary biliary cirrhosis	0.00523	0.00707	CcSEcCtD
L-DOPA—Blood creatinine increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.0049	0.00662	CcSEcCtD
L-DOPA—Blood creatinine increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.0049	0.00662	CcSEcCtD
L-DOPA—Orthostatic hypotension—Ursodeoxycholic acid—primary biliary cirrhosis	0.00477	0.00645	CcSEcCtD
L-DOPA—Orthostatic hypotension—Chenodeoxycholic acid—primary biliary cirrhosis	0.00477	0.00645	CcSEcCtD
L-DOPA—Cramp muscle—Ursodeoxycholic acid—primary biliary cirrhosis	0.00471	0.00636	CcSEcCtD
L-DOPA—Cramp muscle—Chenodeoxycholic acid—primary biliary cirrhosis	0.00471	0.00636	CcSEcCtD
L-DOPA—Gastritis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00463	0.00625	CcSEcCtD
L-DOPA—Gastritis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00463	0.00625	CcSEcCtD
L-DOPA—Dysphagia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00452	0.00611	CcSEcCtD
L-DOPA—Dysphagia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00452	0.00611	CcSEcCtD
L-DOPA—Angina pectoris—Chenodeoxycholic acid—primary biliary cirrhosis	0.0044	0.00595	CcSEcCtD
L-DOPA—Angina pectoris—Ursodeoxycholic acid—primary biliary cirrhosis	0.0044	0.00595	CcSEcCtD
L-DOPA—Neuropathy peripheral—Colchicine—primary biliary cirrhosis	0.0044	0.00594	CcSEcCtD
L-DOPA—Upper respiratory tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.0042	0.00568	CcSEcCtD
L-DOPA—Upper respiratory tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.0042	0.00568	CcSEcCtD
L-DOPA—Agranulocytosis—Colchicine—primary biliary cirrhosis	0.00418	0.00566	CcSEcCtD
L-DOPA—Pollakiuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.00417	0.00564	CcSEcCtD
L-DOPA—Pollakiuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.00417	0.00564	CcSEcCtD
L-DOPA—Weight increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00411	0.00556	CcSEcCtD
L-DOPA—Weight increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00411	0.00556	CcSEcCtD
L-DOPA—Weight decreased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00409	0.00552	CcSEcCtD
L-DOPA—Weight decreased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00409	0.00552	CcSEcCtD
L-DOPA—Depression—Chenodeoxycholic acid—primary biliary cirrhosis	0.00402	0.00543	CcSEcCtD
L-DOPA—Depression—Ursodeoxycholic acid—primary biliary cirrhosis	0.00402	0.00543	CcSEcCtD
L-DOPA—Hypoaesthesia—Colchicine—primary biliary cirrhosis	0.00401	0.00541	CcSEcCtD
L-DOPA—Acute coronary syndrome—Ursodeoxycholic acid—primary biliary cirrhosis	0.00397	0.00537	CcSEcCtD
L-DOPA—Acute coronary syndrome—Chenodeoxycholic acid—primary biliary cirrhosis	0.00397	0.00537	CcSEcCtD
L-DOPA—Myocardial infarction—Ursodeoxycholic acid—primary biliary cirrhosis	0.00395	0.00534	CcSEcCtD
L-DOPA—Myocardial infarction—Chenodeoxycholic acid—primary biliary cirrhosis	0.00395	0.00534	CcSEcCtD
L-DOPA—Urinary tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.00392	0.00529	CcSEcCtD
L-DOPA—Urinary tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.00392	0.00529	CcSEcCtD
L-DOPA—Haemoglobin—Chenodeoxycholic acid—primary biliary cirrhosis	0.00364	0.00491	CcSEcCtD
L-DOPA—Haemoglobin—Ursodeoxycholic acid—primary biliary cirrhosis	0.00364	0.00491	CcSEcCtD
L-DOPA—Rhinitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00363	0.0049	CcSEcCtD
L-DOPA—Rhinitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00363	0.0049	CcSEcCtD
L-DOPA—Haemorrhage—Ursodeoxycholic acid—primary biliary cirrhosis	0.00362	0.00489	CcSEcCtD
L-DOPA—Haemorrhage—Chenodeoxycholic acid—primary biliary cirrhosis	0.00362	0.00489	CcSEcCtD
L-DOPA—Urinary tract disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00357	0.00483	CcSEcCtD
L-DOPA—Urinary tract disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00357	0.00483	CcSEcCtD
L-DOPA—Alopecia—Colchicine—primary biliary cirrhosis	0.00356	0.00481	CcSEcCtD
L-DOPA—Urethral disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00355	0.00479	CcSEcCtD
L-DOPA—Urethral disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00355	0.00479	CcSEcCtD
L-DOPA—Muscle spasms—Colchicine—primary biliary cirrhosis	0.00337	0.00455	CcSEcCtD
L-DOPA—Anaemia—Colchicine—primary biliary cirrhosis	0.00324	0.00438	CcSEcCtD
L-DOPA—Arrhythmia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00323	0.00437	CcSEcCtD
L-DOPA—Arrhythmia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00323	0.00437	CcSEcCtD
L-DOPA—Angioedema—Colchicine—primary biliary cirrhosis	0.0032	0.00433	CcSEcCtD
L-DOPA—Alopecia—Ursodeoxycholic acid—primary biliary cirrhosis	0.0032	0.00432	CcSEcCtD
L-DOPA—Alopecia—Chenodeoxycholic acid—primary biliary cirrhosis	0.0032	0.00432	CcSEcCtD
L-DOPA—Leukopenia—Colchicine—primary biliary cirrhosis	0.00314	0.00424	CcSEcCtD
L-DOPA—Flatulence—Chenodeoxycholic acid—primary biliary cirrhosis	0.0031	0.00419	CcSEcCtD
L-DOPA—Flatulence—Ursodeoxycholic acid—primary biliary cirrhosis	0.0031	0.00419	CcSEcCtD
L-DOPA—Tension—Ursodeoxycholic acid—primary biliary cirrhosis	0.00309	0.00418	CcSEcCtD
L-DOPA—Tension—Chenodeoxycholic acid—primary biliary cirrhosis	0.00309	0.00418	CcSEcCtD
L-DOPA—Nervousness—Chenodeoxycholic acid—primary biliary cirrhosis	0.00306	0.00413	CcSEcCtD
L-DOPA—Nervousness—Ursodeoxycholic acid—primary biliary cirrhosis	0.00306	0.00413	CcSEcCtD
L-DOPA—Back pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00305	0.00412	CcSEcCtD
L-DOPA—Back pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00305	0.00412	CcSEcCtD
L-DOPA—Muscle spasms—Ursodeoxycholic acid—primary biliary cirrhosis	0.00303	0.00409	CcSEcCtD
L-DOPA—Muscle spasms—Chenodeoxycholic acid—primary biliary cirrhosis	0.00303	0.00409	CcSEcCtD
L-DOPA—Ill-defined disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00292	0.00395	CcSEcCtD
L-DOPA—Ill-defined disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00292	0.00395	CcSEcCtD
L-DOPA—Anaemia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00291	0.00393	CcSEcCtD
L-DOPA—Anaemia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00291	0.00393	CcSEcCtD
L-DOPA—Angioedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.00288	0.00389	CcSEcCtD
L-DOPA—Angioedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.00288	0.00389	CcSEcCtD
L-DOPA—Malaise—Chenodeoxycholic acid—primary biliary cirrhosis	0.00284	0.00384	CcSEcCtD
L-DOPA—Malaise—Ursodeoxycholic acid—primary biliary cirrhosis	0.00284	0.00384	CcSEcCtD
L-DOPA—Syncope—Chenodeoxycholic acid—primary biliary cirrhosis	0.00282	0.00382	CcSEcCtD
L-DOPA—Syncope—Ursodeoxycholic acid—primary biliary cirrhosis	0.00282	0.00382	CcSEcCtD
L-DOPA—Leukopenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00282	0.00381	CcSEcCtD
L-DOPA—Leukopenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00282	0.00381	CcSEcCtD
L-DOPA—Shock—Colchicine—primary biliary cirrhosis	0.00281	0.0038	CcSEcCtD
L-DOPA—Thrombocytopenia—Colchicine—primary biliary cirrhosis	0.0028	0.00378	CcSEcCtD
L-DOPA—Palpitations—Chenodeoxycholic acid—primary biliary cirrhosis	0.00278	0.00376	CcSEcCtD
L-DOPA—Palpitations—Ursodeoxycholic acid—primary biliary cirrhosis	0.00278	0.00376	CcSEcCtD
L-DOPA—Loss of consciousness—Chenodeoxycholic acid—primary biliary cirrhosis	0.00277	0.00374	CcSEcCtD
L-DOPA—Loss of consciousness—Ursodeoxycholic acid—primary biliary cirrhosis	0.00277	0.00374	CcSEcCtD
L-DOPA—Cough—Ursodeoxycholic acid—primary biliary cirrhosis	0.00275	0.00371	CcSEcCtD
L-DOPA—Cough—Chenodeoxycholic acid—primary biliary cirrhosis	0.00275	0.00371	CcSEcCtD
L-DOPA—Convulsion—Ursodeoxycholic acid—primary biliary cirrhosis	0.00273	0.00369	CcSEcCtD
L-DOPA—Convulsion—Chenodeoxycholic acid—primary biliary cirrhosis	0.00273	0.00369	CcSEcCtD
L-DOPA—Hypertension—Chenodeoxycholic acid—primary biliary cirrhosis	0.00272	0.00367	CcSEcCtD
L-DOPA—Hypertension—Ursodeoxycholic acid—primary biliary cirrhosis	0.00272	0.00367	CcSEcCtD
L-DOPA—Chest pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00268	0.00362	CcSEcCtD
L-DOPA—Chest pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00268	0.00362	CcSEcCtD
L-DOPA—Hypotension—Colchicine—primary biliary cirrhosis	0.00267	0.00361	CcSEcCtD
L-DOPA—Discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.00265	0.00358	CcSEcCtD
L-DOPA—Discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.00265	0.00358	CcSEcCtD
L-DOPA—Dry mouth—Ursodeoxycholic acid—primary biliary cirrhosis	0.00262	0.00354	CcSEcCtD
L-DOPA—Dry mouth—Chenodeoxycholic acid—primary biliary cirrhosis	0.00262	0.00354	CcSEcCtD
L-DOPA—Confusional state—Ursodeoxycholic acid—primary biliary cirrhosis	0.00259	0.0035	CcSEcCtD
L-DOPA—Confusional state—Chenodeoxycholic acid—primary biliary cirrhosis	0.00259	0.0035	CcSEcCtD
L-DOPA—Oedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.00257	0.00347	CcSEcCtD
L-DOPA—Oedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.00257	0.00347	CcSEcCtD
L-DOPA—Shock—Chenodeoxycholic acid—primary biliary cirrhosis	0.00253	0.00342	CcSEcCtD
L-DOPA—Shock—Ursodeoxycholic acid—primary biliary cirrhosis	0.00253	0.00342	CcSEcCtD
L-DOPA—Thrombocytopenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00252	0.0034	CcSEcCtD
L-DOPA—Thrombocytopenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00252	0.0034	CcSEcCtD
L-DOPA—Decreased appetite—Colchicine—primary biliary cirrhosis	0.00249	0.00336	CcSEcCtD
L-DOPA—Hyperhidrosis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00248	0.00336	CcSEcCtD
L-DOPA—Hyperhidrosis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00248	0.00336	CcSEcCtD
L-DOPA—Gastrointestinal disorder—Colchicine—primary biliary cirrhosis	0.00247	0.00334	CcSEcCtD
L-DOPA—Fatigue—Colchicine—primary biliary cirrhosis	0.00247	0.00333	CcSEcCtD
L-DOPA—Anorexia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00245	0.00331	CcSEcCtD
L-DOPA—Anorexia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00245	0.00331	CcSEcCtD
L-DOPA—Hypotension—Chenodeoxycholic acid—primary biliary cirrhosis	0.0024	0.00324	CcSEcCtD
L-DOPA—Hypotension—Ursodeoxycholic acid—primary biliary cirrhosis	0.0024	0.00324	CcSEcCtD
L-DOPA—Gastrointestinal pain—Colchicine—primary biliary cirrhosis	0.00234	0.00316	CcSEcCtD
L-DOPA—Insomnia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00232	0.00314	CcSEcCtD
L-DOPA—Insomnia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00232	0.00314	CcSEcCtD
L-DOPA—Paraesthesia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00231	0.00312	CcSEcCtD
L-DOPA—Paraesthesia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00231	0.00312	CcSEcCtD
L-DOPA—Dyspnoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.00229	0.0031	CcSEcCtD
L-DOPA—Dyspnoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.00229	0.0031	CcSEcCtD
L-DOPA—Somnolence—Ursodeoxycholic acid—primary biliary cirrhosis	0.00228	0.00309	CcSEcCtD
L-DOPA—Somnolence—Chenodeoxycholic acid—primary biliary cirrhosis	0.00228	0.00309	CcSEcCtD
L-DOPA—Urticaria—Colchicine—primary biliary cirrhosis	0.00227	0.00307	CcSEcCtD
L-DOPA—Dyspepsia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00226	0.00306	CcSEcCtD
L-DOPA—Dyspepsia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00226	0.00306	CcSEcCtD
L-DOPA—Abdominal pain—Colchicine—primary biliary cirrhosis	0.00226	0.00306	CcSEcCtD
L-DOPA—Decreased appetite—Chenodeoxycholic acid—primary biliary cirrhosis	0.00223	0.00302	CcSEcCtD
L-DOPA—Decreased appetite—Ursodeoxycholic acid—primary biliary cirrhosis	0.00223	0.00302	CcSEcCtD
L-DOPA—Gastrointestinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00222	0.003	CcSEcCtD
L-DOPA—Gastrointestinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00222	0.003	CcSEcCtD
L-DOPA—Fatigue—Chenodeoxycholic acid—primary biliary cirrhosis	0.00222	0.00299	CcSEcCtD
L-DOPA—Fatigue—Ursodeoxycholic acid—primary biliary cirrhosis	0.00222	0.00299	CcSEcCtD
L-DOPA—Pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.0022	0.00297	CcSEcCtD
L-DOPA—Pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.0022	0.00297	CcSEcCtD
L-DOPA—Constipation—Ursodeoxycholic acid—primary biliary cirrhosis	0.0022	0.00297	CcSEcCtD
L-DOPA—Constipation—Chenodeoxycholic acid—primary biliary cirrhosis	0.0022	0.00297	CcSEcCtD
L-DOPA—Feeling abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.00212	0.00286	CcSEcCtD
L-DOPA—Feeling abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.00212	0.00286	CcSEcCtD
L-DOPA—Hypersensitivity—Colchicine—primary biliary cirrhosis	0.00211	0.00285	CcSEcCtD
L-DOPA—Gastrointestinal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.0021	0.00284	CcSEcCtD
L-DOPA—Gastrointestinal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.0021	0.00284	CcSEcCtD
L-DOPA—Asthenia—Colchicine—primary biliary cirrhosis	0.00205	0.00277	CcSEcCtD
L-DOPA—Urticaria—Chenodeoxycholic acid—primary biliary cirrhosis	0.00204	0.00276	CcSEcCtD
L-DOPA—Urticaria—Ursodeoxycholic acid—primary biliary cirrhosis	0.00204	0.00276	CcSEcCtD
L-DOPA—Abdominal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00203	0.00275	CcSEcCtD
L-DOPA—Abdominal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00203	0.00275	CcSEcCtD
L-DOPA—Diarrhoea—Colchicine—primary biliary cirrhosis	0.00196	0.00264	CcSEcCtD
L-DOPA—Hypersensitivity—Ursodeoxycholic acid—primary biliary cirrhosis	0.00189	0.00256	CcSEcCtD
L-DOPA—Hypersensitivity—Chenodeoxycholic acid—primary biliary cirrhosis	0.00189	0.00256	CcSEcCtD
L-DOPA—Asthenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00184	0.00249	CcSEcCtD
L-DOPA—Asthenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00184	0.00249	CcSEcCtD
L-DOPA—Vomiting—Colchicine—primary biliary cirrhosis	0.00182	0.00246	CcSEcCtD
L-DOPA—Pruritus—Chenodeoxycholic acid—primary biliary cirrhosis	0.00182	0.00246	CcSEcCtD
L-DOPA—Pruritus—Ursodeoxycholic acid—primary biliary cirrhosis	0.00182	0.00246	CcSEcCtD
L-DOPA—Rash—Colchicine—primary biliary cirrhosis	0.0018	0.00244	CcSEcCtD
L-DOPA—Dermatitis—Colchicine—primary biliary cirrhosis	0.0018	0.00243	CcSEcCtD
L-DOPA—Headache—Colchicine—primary biliary cirrhosis	0.00179	0.00242	CcSEcCtD
L-DOPA—Diarrhoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.00176	0.00238	CcSEcCtD
L-DOPA—Diarrhoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.00176	0.00238	CcSEcCtD
L-DOPA—Dizziness—Ursodeoxycholic acid—primary biliary cirrhosis	0.0017	0.0023	CcSEcCtD
L-DOPA—Dizziness—Chenodeoxycholic acid—primary biliary cirrhosis	0.0017	0.0023	CcSEcCtD
L-DOPA—Nausea—Colchicine—primary biliary cirrhosis	0.0017	0.0023	CcSEcCtD
L-DOPA—Vomiting—Ursodeoxycholic acid—primary biliary cirrhosis	0.00163	0.00221	CcSEcCtD
L-DOPA—Vomiting—Chenodeoxycholic acid—primary biliary cirrhosis	0.00163	0.00221	CcSEcCtD
L-DOPA—Rash—Ursodeoxycholic acid—primary biliary cirrhosis	0.00162	0.00219	CcSEcCtD
L-DOPA—Rash—Chenodeoxycholic acid—primary biliary cirrhosis	0.00162	0.00219	CcSEcCtD
L-DOPA—Dermatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00162	0.00219	CcSEcCtD
L-DOPA—Dermatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00162	0.00219	CcSEcCtD
L-DOPA—Headache—Chenodeoxycholic acid—primary biliary cirrhosis	0.00161	0.00218	CcSEcCtD
L-DOPA—Headache—Ursodeoxycholic acid—primary biliary cirrhosis	0.00161	0.00218	CcSEcCtD
L-DOPA—Nausea—Ursodeoxycholic acid—primary biliary cirrhosis	0.00153	0.00206	CcSEcCtD
L-DOPA—Nausea—Chenodeoxycholic acid—primary biliary cirrhosis	0.00153	0.00206	CcSEcCtD
L-DOPA—DRD3—Class A/1 (Rhodopsin-like receptors)—CXCR5—primary biliary cirrhosis	0.000733	0.00282	CbGpPWpGaD
L-DOPA—DRD2—G alpha (i) signalling events—CXCR5—primary biliary cirrhosis	0.000705	0.00271	CbGpPWpGaD
L-DOPA—SLC7A8—SLC-mediated transmembrane transport—ALB—primary biliary cirrhosis	0.000691	0.00266	CbGpPWpGaD
L-DOPA—DRD1—Class A/1 (Rhodopsin-like receptors)—CXCL9—primary biliary cirrhosis	0.000674	0.00259	CbGpPWpGaD
L-DOPA—DRD3—Class A/1 (Rhodopsin-like receptors)—CXCL9—primary biliary cirrhosis	0.000665	0.00256	CbGpPWpGaD
L-DOPA—PSIP1—Disease—GOT2—primary biliary cirrhosis	0.000655	0.00252	CbGpPWpGaD
L-DOPA—DRD2—GPCRs, Class A Rhodopsin-like—CXCR5—primary biliary cirrhosis	0.000654	0.00252	CbGpPWpGaD
L-DOPA—DRD2—G alpha (i) signalling events—CXCL9—primary biliary cirrhosis	0.00064	0.00246	CbGpPWpGaD
L-DOPA—SLC16A10—Transmembrane transport of small molecules—AQP4—primary biliary cirrhosis	0.00064	0.00246	CbGpPWpGaD
L-DOPA—DDC—Circadian rythm related genes—NOS2—primary biliary cirrhosis	0.00063	0.00242	CbGpPWpGaD
L-DOPA—DRD4—GPCR ligand binding—CXCR5—primary biliary cirrhosis	0.000628	0.00242	CbGpPWpGaD
L-DOPA—SLC16A10—Transmembrane transport of small molecules—ABCC2—primary biliary cirrhosis	0.000613	0.00236	CbGpPWpGaD
L-DOPA—SLC7A5—SLC-mediated transmembrane transport—ALB—primary biliary cirrhosis	0.000603	0.00232	CbGpPWpGaD
L-DOPA—DRD4—GPCR ligand binding—CXCL9—primary biliary cirrhosis	0.00057	0.00219	CbGpPWpGaD
L-DOPA—PSIP1—Disease—GOT1—primary biliary cirrhosis	0.000566	0.00218	CbGpPWpGaD
L-DOPA—DRD1—GPCR ligand binding—CXCR5—primary biliary cirrhosis	0.000565	0.00217	CbGpPWpGaD
L-DOPA—DDC—Metabolism—OGDH—primary biliary cirrhosis	0.000561	0.00216	CbGpPWpGaD
L-DOPA—SLC16A10—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	0.000561	0.00216	CbGpPWpGaD
L-DOPA—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCR5—primary biliary cirrhosis	0.000561	0.00216	CbGpPWpGaD
L-DOPA—DRD3—GPCR ligand binding—CXCR5—primary biliary cirrhosis	0.000558	0.00215	CbGpPWpGaD
L-DOPA—DRD5—Class A/1 (Rhodopsin-like receptors)—CXCL10—primary biliary cirrhosis	0.000529	0.00203	CbGpPWpGaD
L-DOPA—SLC16A10—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	0.000521	0.00201	CbGpPWpGaD
L-DOPA—DRD4—Circadian rythm related genes—PPARGC1A—primary biliary cirrhosis	0.000514	0.00198	CbGpPWpGaD
L-DOPA—DRD1—GPCR ligand binding—CXCL9—primary biliary cirrhosis	0.000513	0.00197	CbGpPWpGaD
L-DOPA—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL9—primary biliary cirrhosis	0.000509	0.00196	CbGpPWpGaD
L-DOPA—DRD3—GPCR ligand binding—CXCL9—primary biliary cirrhosis	0.000507	0.00195	CbGpPWpGaD
L-DOPA—DDC—Metabolism—PDHX—primary biliary cirrhosis	0.0005	0.00192	CbGpPWpGaD
L-DOPA—SLC15A1—Transmembrane transport of small molecules—AQP4—primary biliary cirrhosis	0.000497	0.00191	CbGpPWpGaD
L-DOPA—DDC—SIDS Susceptibility Pathways—NFKB1—primary biliary cirrhosis	0.000493	0.00189	CbGpPWpGaD
L-DOPA—DRD4—G alpha (i) signalling events—CXCL10—primary biliary cirrhosis	0.000491	0.00189	CbGpPWpGaD
L-DOPA—SLC7A8—Hemostasis—NOS2—primary biliary cirrhosis	0.000483	0.00186	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	0.000481	0.00185	CbGpPWpGaD
L-DOPA—SLC15A1—Transmembrane transport of small molecules—ABCC2—primary biliary cirrhosis	0.000476	0.00183	CbGpPWpGaD
L-DOPA—DDC—Metabolism—ABCB4—primary biliary cirrhosis	0.00047	0.00181	CbGpPWpGaD
L-DOPA—DDC—Metabolism—DLAT—primary biliary cirrhosis	0.00047	0.00181	CbGpPWpGaD
L-DOPA—DRD1—Circadian rythm related genes—PPARGC1A—primary biliary cirrhosis	0.000463	0.00178	CbGpPWpGaD
L-DOPA—DRD3—Circadian rythm related genes—PPARGC1A—primary biliary cirrhosis	0.000457	0.00176	CbGpPWpGaD
L-DOPA—DRD5—Class A/1 (Rhodopsin-like receptors)—CCL5—primary biliary cirrhosis	0.000455	0.00175	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—CXCR5—primary biliary cirrhosis	0.000437	0.00168	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	0.000437	0.00168	CbGpPWpGaD
L-DOPA—DRD3—G alpha (i) signalling events—CXCL10—primary biliary cirrhosis	0.000436	0.00168	CbGpPWpGaD
L-DOPA—SLC15A1—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	0.000436	0.00168	CbGpPWpGaD
L-DOPA—CYP2D6—Melatonin metabolism and effects—NFKB1—primary biliary cirrhosis	0.000435	0.00167	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—CXCR5—primary biliary cirrhosis	0.000427	0.00164	CbGpPWpGaD
L-DOPA—DRD4—G alpha (i) signalling events—CCL5—primary biliary cirrhosis	0.000422	0.00162	CbGpPWpGaD
L-DOPA—SLC7A5—Hemostasis—NOS2—primary biliary cirrhosis	0.000421	0.00162	CbGpPWpGaD
L-DOPA—SLC7A8—Hemostasis—ALB—primary biliary cirrhosis	0.000406	0.00156	CbGpPWpGaD
L-DOPA—SLC15A1—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	0.000405	0.00156	CbGpPWpGaD
L-DOPA—DRD5—GPCR ligand binding—CXCL10—primary biliary cirrhosis	0.000403	0.00155	CbGpPWpGaD
L-DOPA—SLC16A10—SLC-mediated transmembrane transport—ALB—primary biliary cirrhosis	0.000401	0.00154	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—CXCL9—primary biliary cirrhosis	0.000397	0.00153	CbGpPWpGaD
L-DOPA—PSIP1—Disease—HIF1A—primary biliary cirrhosis	0.000394	0.00151	CbGpPWpGaD
L-DOPA—DRD4—Class A/1 (Rhodopsin-like receptors)—CXCL10—primary biliary cirrhosis	0.00039	0.0015	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—CXCL9—primary biliary cirrhosis	0.000388	0.00149	CbGpPWpGaD
L-DOPA—DRD5—Class A/1 (Rhodopsin-like receptors)—AGT—primary biliary cirrhosis	0.000381	0.00146	CbGpPWpGaD
L-DOPA—DRD3—G alpha (i) signalling events—CCL5—primary biliary cirrhosis	0.000375	0.00144	CbGpPWpGaD
L-DOPA—DRD4—Circadian rythm related genes—NOS2—primary biliary cirrhosis	0.000366	0.00141	CbGpPWpGaD
L-DOPA—PSIP1—Disease—NOS2—primary biliary cirrhosis	0.000358	0.00138	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	0.000355	0.00136	CbGpPWpGaD
L-DOPA—SLC7A5—Hemostasis—ALB—primary biliary cirrhosis	0.000354	0.00136	CbGpPWpGaD
L-DOPA—DRD4—G alpha (i) signalling events—AGT—primary biliary cirrhosis	0.000353	0.00136	CbGpPWpGaD
L-DOPA—DRD1—Class A/1 (Rhodopsin-like receptors)—CXCL10—primary biliary cirrhosis	0.000351	0.00135	CbGpPWpGaD
L-DOPA—SLC7A8—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	0.000351	0.00135	CbGpPWpGaD
L-DOPA—DRD2—Circadian rythm related genes—PPARGC1A—primary biliary cirrhosis	0.000349	0.00134	CbGpPWpGaD
L-DOPA—PSIP1—Disease—CD80—primary biliary cirrhosis	0.000347	0.00134	CbGpPWpGaD
L-DOPA—DRD3—Class A/1 (Rhodopsin-like receptors)—CXCL10—primary biliary cirrhosis	0.000347	0.00133	CbGpPWpGaD
L-DOPA—DRD5—GPCR ligand binding—CCL5—primary biliary cirrhosis	0.000346	0.00133	CbGpPWpGaD
L-DOPA—DRD4—Class A/1 (Rhodopsin-like receptors)—CCL5—primary biliary cirrhosis	0.000336	0.00129	CbGpPWpGaD
L-DOPA—DRD2—G alpha (i) signalling events—CXCL10—primary biliary cirrhosis	0.000333	0.00128	CbGpPWpGaD
L-DOPA—DRD1—Circadian rythm related genes—NOS2—primary biliary cirrhosis	0.000329	0.00127	CbGpPWpGaD
L-DOPA—DRD3—Circadian rythm related genes—NOS2—primary biliary cirrhosis	0.000325	0.00125	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—CXCR5—primary biliary cirrhosis	0.000322	0.00124	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	0.000322	0.00124	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	0.00032	0.00123	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	0.000315	0.00121	CbGpPWpGaD
L-DOPA—DRD3—G alpha (i) signalling events—AGT—primary biliary cirrhosis	0.000314	0.00121	CbGpPWpGaD
L-DOPA—SLC15A1—SLC-mediated transmembrane transport—ALB—primary biliary cirrhosis	0.000311	0.0012	CbGpPWpGaD
L-DOPA—SLC7A5—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	0.000306	0.00118	CbGpPWpGaD
L-DOPA—DRD1—Class A/1 (Rhodopsin-like receptors)—CCL5—primary biliary cirrhosis	0.000302	0.00116	CbGpPWpGaD
L-DOPA—DRD3—Class A/1 (Rhodopsin-like receptors)—CCL5—primary biliary cirrhosis	0.000298	0.00115	CbGpPWpGaD
L-DOPA—DRD4—GPCR ligand binding—CXCL10—primary biliary cirrhosis	0.000297	0.00114	CbGpPWpGaD
L-DOPA—PSIP1—Disease—TYK2—primary biliary cirrhosis	0.000293	0.00113	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—CXCL9—primary biliary cirrhosis	0.000293	0.00113	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—CXCR5—primary biliary cirrhosis	0.00029	0.00112	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	0.00029	0.00112	CbGpPWpGaD
L-DOPA—DRD5—GPCR ligand binding—AGT—primary biliary cirrhosis	0.00029	0.00111	CbGpPWpGaD
L-DOPA—DRD2—G alpha (i) signalling events—CCL5—primary biliary cirrhosis	0.000287	0.0011	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—CXCR5—primary biliary cirrhosis	0.000286	0.0011	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	0.000286	0.0011	CbGpPWpGaD
L-DOPA—DDC—Metabolism—NUP210—primary biliary cirrhosis	0.000283	0.00109	CbGpPWpGaD
L-DOPA—DRD4—Class A/1 (Rhodopsin-like receptors)—AGT—primary biliary cirrhosis	0.000281	0.00108	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CDH5—primary biliary cirrhosis	0.000268	0.00103	CbGpPWpGaD
L-DOPA—DRD1—GPCR ligand binding—CXCL10—primary biliary cirrhosis	0.000267	0.00103	CbGpPWpGaD
L-DOPA—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL10—primary biliary cirrhosis	0.000265	0.00102	CbGpPWpGaD
L-DOPA—DRD3—GPCR ligand binding—CXCL10—primary biliary cirrhosis	0.000264	0.00101	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—CXCL9—primary biliary cirrhosis	0.000263	0.00101	CbGpPWpGaD
L-DOPA—DDC—Metabolism—ABCG2—primary biliary cirrhosis	0.000263	0.00101	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—CXCL9—primary biliary cirrhosis	0.00026	0.001	CbGpPWpGaD
L-DOPA—CYP2D6—Biological oxidations—GGT1—primary biliary cirrhosis	0.000259	0.000998	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CXCR5—primary biliary cirrhosis	0.000258	0.000992	CbGpPWpGaD
L-DOPA—DRD4—GPCR ligand binding—CCL5—primary biliary cirrhosis	0.000256	0.000983	CbGpPWpGaD
L-DOPA—DRD1—Class A/1 (Rhodopsin-like receptors)—AGT—primary biliary cirrhosis	0.000253	0.000972	CbGpPWpGaD
L-DOPA—DRD3—Class A/1 (Rhodopsin-like receptors)—AGT—primary biliary cirrhosis	0.00025	0.00096	CbGpPWpGaD
L-DOPA—DRD2—Circadian rythm related genes—NOS2—primary biliary cirrhosis	0.000248	0.000955	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	0.000241	0.000928	CbGpPWpGaD
L-DOPA—DRD2—G alpha (i) signalling events—AGT—primary biliary cirrhosis	0.00024	0.000923	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CXCL9—primary biliary cirrhosis	0.000234	0.000901	CbGpPWpGaD
L-DOPA—DRD1—GPCR ligand binding—CCL5—primary biliary cirrhosis	0.00023	0.000885	CbGpPWpGaD
L-DOPA—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL5—primary biliary cirrhosis	0.000228	0.000878	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	0.000227	0.000875	CbGpPWpGaD
L-DOPA—DRD3—GPCR ligand binding—CCL5—primary biliary cirrhosis	0.000227	0.000874	CbGpPWpGaD
L-DOPA—DDC—Metabolism—CTGF—primary biliary cirrhosis	0.000226	0.000867	CbGpPWpGaD
L-DOPA—DDC—Metabolism—GOT2—primary biliary cirrhosis	0.000223	0.000859	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—CXCR5—primary biliary cirrhosis	0.000219	0.000843	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	0.000219	0.000842	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—ELMO1—primary biliary cirrhosis	0.000217	0.000834	CbGpPWpGaD
L-DOPA—DRD4—GPCR ligand binding—AGT—primary biliary cirrhosis	0.000214	0.000823	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—CXCL10—primary biliary cirrhosis	0.000207	0.000794	CbGpPWpGaD
L-DOPA—SLC16A10—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	0.000204	0.000783	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—CXCL10—primary biliary cirrhosis	0.000202	0.000776	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—CXCL9—primary biliary cirrhosis	0.000199	0.000765	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CDH5—primary biliary cirrhosis	0.000198	0.000761	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—CCL5—primary biliary cirrhosis	0.000196	0.000753	CbGpPWpGaD
L-DOPA—DDC—Metabolism—GGT1—primary biliary cirrhosis	0.000193	0.000742	CbGpPWpGaD
L-DOPA—DDC—Metabolism—GOT1—primary biliary cirrhosis	0.000193	0.000742	CbGpPWpGaD
L-DOPA—DRD1—GPCR ligand binding—AGT—primary biliary cirrhosis	0.000193	0.000741	CbGpPWpGaD
L-DOPA—DRD2—Class A/1 (Rhodopsin-like receptors)—AGT—primary biliary cirrhosis	0.000191	0.000734	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CXCR5—primary biliary cirrhosis	0.00019	0.000732	CbGpPWpGaD
L-DOPA—DRD3—GPCR ligand binding—AGT—primary biliary cirrhosis	0.00019	0.000731	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—MMP3—primary biliary cirrhosis	0.000188	0.000724	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—LBR—primary biliary cirrhosis	0.000179	0.000687	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CDH5—primary biliary cirrhosis	0.000178	0.000685	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—CCL5—primary biliary cirrhosis	0.000178	0.000684	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CDH5—primary biliary cirrhosis	0.000176	0.000676	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—CCL5—primary biliary cirrhosis	0.000174	0.000668	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CXCL9—primary biliary cirrhosis	0.000173	0.000665	CbGpPWpGaD
L-DOPA—DDC—Metabolism—PPARGC1A—primary biliary cirrhosis	0.000172	0.00066	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CXCR5—primary biliary cirrhosis	0.000171	0.000659	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CXCR5—primary biliary cirrhosis	0.000169	0.00065	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	0.000168	0.000646	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—AGT—primary biliary cirrhosis	0.000164	0.00063	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—ELMO1—primary biliary cirrhosis	0.00016	0.000615	CbGpPWpGaD
L-DOPA—SLC15A1—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	0.000158	0.000608	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CXCL9—primary biliary cirrhosis	0.000156	0.000599	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CXCL9—primary biliary cirrhosis	0.000154	0.000591	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—CXCL10—primary biliary cirrhosis	0.000152	0.000586	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	0.000151	0.000581	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	0.000149	0.000573	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—AGT—primary biliary cirrhosis	0.000149	0.000572	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—AGT—primary biliary cirrhosis	0.000145	0.000559	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—CCL5—primary biliary cirrhosis	0.000145	0.000556	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—ELMO1—primary biliary cirrhosis	0.000144	0.000554	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—ELMO1—primary biliary cirrhosis	0.000142	0.000546	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—MMP3—primary biliary cirrhosis	0.000139	0.000535	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—CXCL10—primary biliary cirrhosis	0.000137	0.000528	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—CXCL10—primary biliary cirrhosis	0.000135	0.000521	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CDH5—primary biliary cirrhosis	0.000134	0.000517	CbGpPWpGaD
L-DOPA—DDC—Metabolism—AGT—primary biliary cirrhosis	0.000134	0.000514	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—CCL5—primary biliary cirrhosis	0.000131	0.000505	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—CCL5—primary biliary cirrhosis	0.00013	0.0005	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CXCR5—primary biliary cirrhosis	0.000129	0.000498	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—OGDH—primary biliary cirrhosis	0.000129	0.000496	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—CCL5—primary biliary cirrhosis	0.000128	0.000494	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—MMP3—primary biliary cirrhosis	0.000125	0.000481	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—MMP3—primary biliary cirrhosis	0.000124	0.000475	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CXCL10—primary biliary cirrhosis	0.000122	0.000469	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—AGT—primary biliary cirrhosis	0.000121	0.000465	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—CCL5—primary biliary cirrhosis	0.000118	0.000454	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CXCL9—primary biliary cirrhosis	0.000118	0.000452	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—CCL5—primary biliary cirrhosis	0.000117	0.000448	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—PDHX—primary biliary cirrhosis	0.000115	0.000442	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	0.000114	0.000439	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—MMP3—primary biliary cirrhosis	0.000111	0.000428	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—TYK2—primary biliary cirrhosis	0.000111	0.000428	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—AGT—primary biliary cirrhosis	0.00011	0.000422	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—AGT—primary biliary cirrhosis	0.000109	0.000419	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—ELMO1—primary biliary cirrhosis	0.000109	0.000418	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—DLAT—primary biliary cirrhosis	0.000108	0.000416	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—ABCB4—primary biliary cirrhosis	0.000108	0.000416	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—AGT—primary biliary cirrhosis	0.000107	0.000413	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CCL5—primary biliary cirrhosis	0.000105	0.000404	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—CXCL10—primary biliary cirrhosis	0.000104	0.000398	CbGpPWpGaD
L-DOPA—DDC—Metabolism—ALB—primary biliary cirrhosis	0.000103	0.000395	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	0.000102	0.000391	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—AGT—primary biliary cirrhosis	9.88e-05	0.00038	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—CCL5—primary biliary cirrhosis	9.82e-05	0.000378	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—AGT—primary biliary cirrhosis	9.75e-05	0.000375	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—MMP3—primary biliary cirrhosis	9.45e-05	0.000363	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CXCL10—primary biliary cirrhosis	9.01e-05	0.000346	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—CCL5—primary biliary cirrhosis	8.92e-05	0.000343	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—HIF1A—primary biliary cirrhosis	8.82e-05	0.000339	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—AGT—primary biliary cirrhosis	8.79e-05	0.000338	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—AGT—primary biliary cirrhosis	8.22e-05	0.000316	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—MMP3—primary biliary cirrhosis	8.21e-05	0.000316	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—TYK2—primary biliary cirrhosis	8.21e-05	0.000316	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CXCL10—primary biliary cirrhosis	8.11e-05	0.000312	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CXCL10—primary biliary cirrhosis	8e-05	0.000308	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CD80—primary biliary cirrhosis	7.78e-05	0.000299	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CCL5—primary biliary cirrhosis	7.75e-05	0.000298	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	7.51e-05	0.000289	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—AGT—primary biliary cirrhosis	7.46e-05	0.000287	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—MMP3—primary biliary cirrhosis	7.39e-05	0.000284	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—TYK2—primary biliary cirrhosis	7.39e-05	0.000284	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—MMP3—primary biliary cirrhosis	7.3e-05	0.000281	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—TYK2—primary biliary cirrhosis	7.29e-05	0.00028	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CCL5—primary biliary cirrhosis	6.98e-05	0.000268	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CCL5—primary biliary cirrhosis	6.89e-05	0.000265	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	6.76e-05	0.00026	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	6.67e-05	0.000257	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—TYK2—primary biliary cirrhosis	6.57e-05	0.000253	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—HIF1A—primary biliary cirrhosis	6.51e-05	0.00025	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—NUP210—primary biliary cirrhosis	6.5e-05	0.00025	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—AGT—primary biliary cirrhosis	6.49e-05	0.000249	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CXCL10—primary biliary cirrhosis	6.12e-05	0.000235	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—ABCG2—primary biliary cirrhosis	6.04e-05	0.000232	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—HIF1A—primary biliary cirrhosis	5.86e-05	0.000225	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—AGT—primary biliary cirrhosis	5.84e-05	0.000225	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—HIF1A—primary biliary cirrhosis	5.78e-05	0.000222	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—AGT—primary biliary cirrhosis	5.76e-05	0.000222	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CD80—primary biliary cirrhosis	5.74e-05	0.000221	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—MMP3—primary biliary cirrhosis	5.58e-05	0.000215	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—TYK2—primary biliary cirrhosis	5.58e-05	0.000215	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CCL5—primary biliary cirrhosis	5.27e-05	0.000203	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—CTGF—primary biliary cirrhosis	5.19e-05	0.000199	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—MMP9—primary biliary cirrhosis	5.17e-05	0.000199	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CD80—primary biliary cirrhosis	5.17e-05	0.000199	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—GOT2—primary biliary cirrhosis	5.14e-05	0.000198	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—NFKB1—primary biliary cirrhosis	5.12e-05	0.000197	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	5.11e-05	0.000196	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CD80—primary biliary cirrhosis	5.1e-05	0.000196	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—TYK2—primary biliary cirrhosis	4.85e-05	0.000186	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—GOT1—primary biliary cirrhosis	4.44e-05	0.000171	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—GGT1—primary biliary cirrhosis	4.44e-05	0.000171	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—HIF1A—primary biliary cirrhosis	4.42e-05	0.00017	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—AGT—primary biliary cirrhosis	4.41e-05	0.00017	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—TYK2—primary biliary cirrhosis	4.37e-05	0.000168	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—TYK2—primary biliary cirrhosis	4.31e-05	0.000166	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—PPARGC1A—primary biliary cirrhosis	3.95e-05	0.000152	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CD80—primary biliary cirrhosis	3.9e-05	0.00015	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—MMP9—primary biliary cirrhosis	3.82e-05	0.000147	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—NFKB1—primary biliary cirrhosis	3.78e-05	0.000145	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—MMP9—primary biliary cirrhosis	3.44e-05	0.000132	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—NFKB1—primary biliary cirrhosis	3.4e-05	0.000131	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—MMP9—primary biliary cirrhosis	3.39e-05	0.00013	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—NFKB1—primary biliary cirrhosis	3.36e-05	0.000129	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—TYK2—primary biliary cirrhosis	3.3e-05	0.000127	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—AGT—primary biliary cirrhosis	3.07e-05	0.000118	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—MMP9—primary biliary cirrhosis	2.6e-05	9.98e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—NFKB1—primary biliary cirrhosis	2.57e-05	9.88e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—ALB—primary biliary cirrhosis	2.36e-05	9.07e-05	CbGpPWpGaD
